(Q24564448)

English

Susceptibility of herpesviruses to cytosine arabinoside: standardization of susceptibility test procedure and relative resistance of herpes simplex type 2 strains

scientific article

In more languages

Statements

scholarly article

0 references

Susceptibility of herpesviruses to cytosine arabinoside: standardization of susceptibility test procedure and relative resistance of herpes simplex type 2 strains (English)

0 references

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

M Fiala

1

0 references

A Chow

2

0 references

L B Guze

3

0 references

language of work or name

0 references

publication date

April 1972

0 references

Antimicrobial Agents and Chemotherapy

0 references

1

0 references

354-7

0 references

4

0 references

Sensitivity of Types 1 and 2 Herpes Simplex Virus to 5-Iodo-2'-Deoxyuridine and 9-beta-d-Arabinofuranosyladenine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444221

27 September 2017

Cytosine arabinoside therapy for disseminated herpes zoster in a patient with IgG pyroglobulinemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444221

27 September 2017

Varicella and cytosine arabinoside

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444221

27 September 2017

Investigation of plaque formation in chick embryo cells as a biological marker for distinguishing herpes virus type 2 from type 1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444221

30 May 2018

CYTOSINE ARABINOSIDE (CA) AND OTHER NUCLEOSIDES IN HERPES VIRUS INFECTIONS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444221

28 November 2018

Influence of Host Cell on Biologic Markers of Types 1 and 2 Herpesvirus hominis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444221

28 November 2018

Severe generalized primary herpes treated with cytarabine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/4364937

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

INHIBITION BY METABOLIC ANALOGUES OF PLAQUE FORMATION BY HERPES ZOSTER AND HERPES SIMPLEX VIRUSES

1 reference

https://pubmed.ncbi.nlm.nih.gov/4364937

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytosine arabinoside therapy for herpesvirus infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/4364937

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CELL CULTURE STUDIES ON ANTIVIRAL AGENTS. I. ACTION OF CYTOSINE ARABINOSIDE AND SOME COMPARISONS WITH 5-IODO-2-DEOXYURIDINE

1 reference

https://pubmed.ncbi.nlm.nih.gov/4364937

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro determinations of viral susceptibility to drugs for possible clinical use

1 reference

https://pubmed.ncbi.nlm.nih.gov/4364937

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.1.4.354

0 references

0 references

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24564448&oldid=1513622515"